<?xml version="1.0" encoding="UTF-8"?>
<p id="Par36">The management of brain metastases presents a significant challenge in oncology. Whole brain radiation therapy (WBRT) is widely given to improve neurological symptoms, stop brain metastasis progression and possibly prolong survival. Unfortunately, neurocognitive functional decline is reported in a significant number of patients who undergo WBRT at rates of 31–57% at 3 months and 48–89% at 1 year [
 <xref ref-type="bibr" rid="CR1">1</xref>].
</p>
